Table 1.
Associations between plasma CCL27 levels and clinical characteristics of the patients with NPC
| Characteristics | No. | Median(range) | P value |
|---|---|---|---|
| Age | 0.8556 | ||
| ≤45 | 52 | 405.35(107.33-1296.94) | |
| >45 | 52 | 383.76(84.03-872.33) | |
| Sex | 0.5555 | ||
| Female | 25 | 375.12(107.33-917.17) | |
| Male | 79 | 403.27(84.03-1296.94) | |
| pT stage | 0.8991 | ||
| PT1-pT2 | 25 | 403.27(217.84-1067.05) | |
| pT3 | 47 | 403.96(84.03-1296.94) | |
| pT4 | 32 | 395.68(108.98-872.26) | |
| pN stage | 0.1946 | ||
| pN 0/1 | 53 | 373.05(84.03-1067.05) | |
| pN 2/3 | 51 | 420.32(109.05-1296.94) | |
| Stage | 0.9685 | ||
| I + II | 13 | 376.25(227.77-1067.05) | |
| III | 50 | 397.70(84.03-1296.94) | |
| IV | 41 | 403.27(108.98-872.26) |